Diagnostic error as a result of drug-laboratory test interactions

Author:

van Balveren Jasmijn A.12,Verboeket-van de Venne Wilhelmine P.H.G.3,Erdem-Eraslan Lale4,de Graaf Albert J.5ORCID,Loot Annemarieke E.6,Musson Ruben E.A.7,Oosterhuis Wytze P.3,Schuijt Martin P.8,van der Sijs Heleen9,Verheul Rolf J.10,de Wolf Holger K.11,Kusters Ron12,Hoedemakers Rein M.J.1

Affiliation:

1. Laboratory for Clinical Chemistry and Haematology , Jeroen Bosch Hospital , ’ s-Hertogenbosch , The Netherlands

2. Department of Health Technology and Services Research, Technical Medical Centre , University of Twente , Enschede , The Netherlands

3. Department of Clinical Chemistry , Zuyderland Medical Centre , Heerlen , The Netherlands

4. Department of Clinical Chemistry , Erasmus University Medical Centre , Rotterdam , The Netherlands

5. Department of Clinical Chemistry , Medical Spectrum Twente , Enschede , The Netherlands

6. Department of Clinical Chemistry, Certe , Groningen , The Netherlands

7. Laboratory for Clinical Chemistry and Haematology , University Medical Centre Utrecht , Utrecht , The Netherlands

8. Department of Clinical Chemistry , Slingeland Hospital , Doetinchem , The Netherlands

9. Department of Hospital Pharmacy, Erasmus Medical Centre , University Medical Centre Rotterdam , Rotterdam , The Netherlands

10. Department of Clinical Chemistry , LabWest/HMC Westeinde , The Hague , The Netherlands

11. Department of Clinical Chemistry , Rivierenland Hospital , Tiel , The Netherlands

Abstract

Abstract Background Knowledge of possible drug-laboratory test interactions (DLTIs) is important for the interpretation of laboratory test results. Test results may be affected by physiological or analytical drug effects. Failure to recognize these interactions may lead to misinterpretation of test results, a delayed or erroneous diagnosis or unnecessary extra tests or therapy, which may harm patients. Content Thousands of interactions have been reported in the literature, but are often fragmentarily described and some papers even reported contradictory findings. How can healthcare professionals become aware of all these possible interactions in their individual patients? DLTI decision support applications could be a good solution. In a literature search, only four relevant studies have been found on DLTI decision support applications in clinical practice. These studies show a potential benefit of automated DLTI messages to physicians for the interpretation of laboratory test results. All physicians reported that part of the DLTI messages were useful. In one study, 74% of physicians even sometimes refrained from further additional examination. Summary and outlook Unrecognized DLTIs potentially cause diagnostic errors in a large number of patients. Therefore, efforts to avoid these errors, for example with a DLTI decision support application, could tremendously improve patient outcome.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,Public Health, Environmental and Occupational Health,Health Policy,Medicine (miscellaneous)

Reference16 articles.

1. Whiting PF, Davenport C, Jameson C, Burke M, Sterne JA, HydeC, et al. How well do health professionals interpret diagnostic information? A systematic review. BMJ Open 2015;5:1–8.

2. Vlasveld LT, van ’t Wout J, Castel A. False elevation of chromogranin A due to proton pump inhibitors. Neth J Med 2011;69:207.

3. Perera NJ, Stewart PM, Williams PF, Chua EL, Yue DK, Twigg SM. The danger of using inappropriate point-of-care glucose meters in patients on icodextrin dialysis. Diabet Med 2011;28:1272–6.

4. FDA. Public health notification: potentially fatal errors with GDH-PQQ glucose monitoring technology, 2009. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm176992.html.

5. Young DS. Effects of drugs on clinical laboratory tests, 5th ed. Washington: American Association of Clinical Chemistry, 2000.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3